BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 27490411)

  • 41. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M; Gitto S; Biselli M
    J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
    Lai JC; Covinsky KE; Hayssen H; Lizaola B; Dodge JL; Roberts JP; Terrault NA; Feng S
    Liver Int; 2015 Sep; 35(9):2167-73. PubMed ID: 25644788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MELD as a metric for survival benefit of liver transplantation.
    Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
    Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving Liver Allocation Using Optimized Neighborhoods.
    Kilambi V; Mehrotra S
    Transplantation; 2017 Feb; 101(2):350-359. PubMed ID: 27906775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.
    Molinari M; Renfrew PD; Petrie NM; De Coutere S; Abdolell M
    Transpl Int; 2011 Mar; 24(3):292-9. PubMed ID: 21143650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study.
    Shaheen AA; Martin SR; Khorsheed S; Abraldes JG
    Liver Transpl; 2024 Mar; 30(3):269-276. PubMed ID: 37655999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
    Malik AK; Masson S; Allen E; Akyol M; Bathgate A; Davies M; Hidalgo E; Hudson M; Powell J; Taylor R; Zarankaite A; Manas DM;
    Transplantation; 2019 Nov; 103(11):2304-2311. PubMed ID: 30830042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study.
    Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Rocha-Santos V; Pinheiro RSN; Nacif LS; D'Albuquerque LAC
    Transplant Proc; 2018 Apr; 50(3):754-757. PubMed ID: 29661430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.
    Gish RG; Wong RJ; Honerkamp-Smith G; Xu R; Osorio RW
    Clin Transplant; 2015 Jun; 29(6):513-22. PubMed ID: 25808918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Geographic differences in access to transplantation in the United States.
    Ellison MD; Edwards LB; Edwards EB; Barker CF
    Transplantation; 2003 Nov; 76(9):1389-94. PubMed ID: 14627922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate.
    Myers RP; Shaheen AA; Aspinall AI; Quinn RR; Burak KW
    J Hepatol; 2011 Mar; 54(3):462-70. PubMed ID: 21109324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates.
    Mogul DB; Perito ER; Wood N; Mazariegos GV; VanDerwerken D; Ibrahim SH; Mohammad S; Valentino PL; Gentry S; Hsu E
    Transplantation; 2020 Aug; 104(8):1627-1632. PubMed ID: 32732840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
    Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
    PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.